General Information of Drug (ID: DMVUU4J)

Drug Name
PERFOSFAMIDE
Synonyms
NPC-15520; Perfosfamide < Rec INN; Pergamid (Scios Nova, US); Rac-cis-2-[Bis(2-chloroethyl)amino]-4-hydroperoxytetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; Rac-cis-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin-4-yl hydroperoxide P-oxide; 4-HC; 4-HPCy; 4-Hydroperoxycyclophosphamide
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C7H15Cl2N2O4P
Canonical SMILES
C1COP(=O)(NC1OO)N(CCCl)CCCl
InChI
InChI=1S/C7H15Cl2N2O4P/c8-2-4-11(5-3-9)16(13)10-7(15-12)1-6-14-16/h7,12H,1-6H2,(H,10,13)/t7-,16-/m1/s1
InChIKey
VPAWVRUHMJVRHU-VGDKGRGNSA-N
Cross-matching ID
PubChem CID
9554809
ChEBI ID
CHEMBL135223
CAS Number
62435-42-1
UNII
U880A4FUDA
DrugBank ID
DB12727
TTD ID
D03ZIS
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT00002634) Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma. U.S. National Institutes of Health.